Across its top 20 institutional holders, EBS's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 9/100, avg. turnover score 29/100).

Quarterly Activity

Recent Activity

+$208.2M

Total Buy Value

$239.0M

Total Sell Value

New buy31

Trim55

Add70

Sold out24

101

Net Buyers

Net Sellers

Smart Money Convergence

EBS does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/EBS

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

Filings (90d)

$25K

Total Est. Value

3K shares

Planned Shares

Last Filed 2026-07-01

Filer	Title/Relationship	Filing Date	Planned Shares	Est. Value
PAUL WILLIAMS	Officer	2026-07-01	3K shares	$25K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

29089Q105

FAQ

Who are the top institutional investors holding EMERGENT BIOSOLUTIONS INC (EBS)?

Major stakeholders currently include BlackRock, Inc. ($36.0M), State Street CORP ($23.7M), Dimensional Fund Advisors LP ($22.9M). Based on the latest 13F filings, there are a total of 191 tracked investment funds and institutions maintaining positions in EBS.

What is the overall institutional sentiment toward EBS recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $130.0M, driven by 101 managers accumulating shares while 79 reduced their exposure.

Which institutions have been selling or reducing their EBS positions?

In the latest period, 55 funds trimmed their holdings, and 24 managers completely exited their positions. The aggregate reported sell value was $239.0M.

Are there any notable investors adding EBS to their portfolios?

Yes, buying activity remains notable. 31 institutions opened new positions in {ticker}, and 70 existing holders added to their shares. The total reported buy value for the quarter amounted to $208.2M.